MCK GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Mckesson Corporation
Exchange: NYSESector: HealthcareIndustry: Medical Distribution
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable.
Did you know?
MCK's revenue grew at a 9.0% CAGR over the last 6 years.
Current Price
$814.02
-0.14%GoodMoat Value
$13906.70
1608.4% undervaluedProfile
Valuation (TTM)
Market Cap$100.47B
P/E23.15
EV$113.91B
P/B—
Shares Out123.43M
P/Sales0.25
Revenue$397.96B
EV/EBITDA16.21
Mckesson Corporation (MCK) Quality Analysis
MCK Profitability
Profitability trend analysis coming soon
MCK Growth
Growth trend analysis coming soon
MCK Financial Health
Financial health indicators coming soon
MCK Quality & Fundamental Analysis
Mckesson Corporation (MCK) is a Healthcare company in the Medical Distribution industry, listed on NYSE. This quality analysis page evaluates Mckesson Corporation's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Mckesson Corporation has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 1.09%. Return on assets (ROA) stands at 5.78%.
with a current ratio of 0.90. Operating margin is 1.23%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Mckesson Corporation is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.